Scientists try to 'Wake Up' immune system to fight tough colon cancer
Disease control
Completed
This study tested if adding an immunotherapy drug (nivolumab) to standard chemotherapy could better control a hard-to-treat type of advanced colorectal cancer. It involved 80 patients who had not received prior treatment for their metastatic cancer. The main goal was to see if th…
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC